Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - March 2013


Clinical Research Operations and Worldwide Networking Summit

20 Mar 2013 - 22 Mar 2013 - PA, USA



Bookmark and Share


C.R.O.W.N. stands for the Clinical Research Operations and Worldwide Networking Summit. The first inaugural CROWN Summit in 2012 was an overwhelming success due to the large turnout of passionate executives dedicated to improving all aspects of the clinical research process.

2013 CROWN BENEFITS

Full Access to 5 Different Clinical Themed Programs for Customization of Your Agenda at NO EXTRA COST

70+ Unique Educational Sessions Spanning the Clinical Research Landscape

Plenary Sessions including “Voice of the Patient”, Executive Panel, and 1st Annual Triple CROWN Awards

4+ Pre-Conference Workshop Sessions Tailored to Your Professional Focus

10 Networking Opportunities including Meals, Breaks, and Receptions

Shared Exhibit Hall Guaranteeing Access to Over 300 Attendees

ONE C.R.O.W.N. LOCATION!

2013 CROWN SESSION STREAMS

6th Lean Sigma for Life Science R&D

4th Collaborative Site/Sponsor Partnerships

7th Forecasting & Optimizing the Clinical Supply Chain

9th Clinical Alliances in Emerging Regions

4th Digital Engagement & Social Media in Clinical Trials

2013 provides us with a new set of challenges to ensure an overall first-class attendee experience from start to end.

Here’s how we are going to do it:

 Fresh Content – Our conference advisory board has made suggestions for how we can keep each track of sessions current and resourceful for the conference attendee:

Last year’s Patient Engagement Technologies track will take a deeper dive into digital and social media platforms clinical research teams are using to communicate with their patients.  To capture this adjustment, this year’s session track will be renamed the 4th Digital Engagement and Social Media in Clinical Trials.

We asked our past attendees and advisory board: how do we strengthen our value proposition to those involved with site related responsibilities?  The answer was focus on current improvements being made to the collaboration process between sites and sponsors and help executives meet the FDA’s expectations.  This year’s 4th Collaborative Site/Sponsor Partnerships will provide attendees a track of sessions focused on managing, monitoring and evaluating the communication between key stakeholders.  This includes examining recent FDA guidance on Quality by Design (QbD) for Risk-Based Clinical Monitoring platforms currently being utilized to improve clinical quality.

ExL’s Latin America Clinical Trials conference was first introduced to the industry in 2008 as a gateway into accessing the LATAM region as a clinical research hub.  Five years later Latin America has gone from a region with potential, to one of the strongest pharmaceutical R&D markets in the world.  This year we will once again tackle the global challenges of coordinating complex clinical trials, but expand our focus to other developing regions as well.  The now 9th Clinical Alliances in Emerging Regions will uncover true opportunities around the world and specifically how working alongside clinical vendors can optimize research efforts conducted within these regions.

 The remaining two tracks of sessions grew in 2012 both in size and scope, producing the best content and experience to date in these given areas.  Our work is cut out for us to ensure they evolve, but the 6th Forecasting & Optimization of the Clinical Supply Chain and 6th Lean Sigma for Life Sciences R&D themes will remain the same.

Power Networking Opportunities – To maximize the experience for all involved, C.R.O.W.N. will incorporate a series of networking breaks, meals, special events and receptions to form connections that matter.  Opportunities for pre-arranged networking based on professional focus help tailor the attendee experience to avoid wasting time looking, and gaining time connecting.

First-Class Experience — Two days of sitting in a cramped seat straddling a table leg?  No surface space to take notes?  Out of coffee?  As someone closely involved in the life science event industry, I have been closed out of must-attend sessions, had to sit on presentation room floors, denied coffee (oh no!), and felt like another face in the crowd.  This year ExL has upgraded to the spacious Commonwealth and Millennium Halls on the second floor of the Loews Philadelphia Hotel and our Event Coordination & Experience Department has worked closely with the Loews to create a comfortable environment fostering information gathering and collaboration.  The attendee experience is our highest priority and we will work hand-in-hand from pre-meeting to onsite to post-event to provide first-class customer service. Period.

The vision for the March 20-22 Summit is to build upon last year’s effort of providing a “one-stop information resource” local for clinical research professionals to network, learn and bring back solution-driven ideas to their respective organizations. All events will share a networking hall, meals and cocktail reception for one of a kind networking opportunities within the convenience of the Philadelphia area.

I look forward to greeting you in March!



Further information
Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
Study Questions Presence in Blood of Heart-Healthy Molecules from Fish Oil Supplements
A new study from the Perelman School of Medicine at the University of Pennsylvania questions the relevance of fish oil-derived SPMs and their purported anti-inflammatory effects in humans.
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
Young South African Women can Adhere to Daily PrEP Regimen as HIV Prevention
NIH-funded study finds men in Bangkok, Harlem also successful in taking daily dose.
Key Player in Diabetic Kidney Disease Revealed
Discovery could lead to new and better diagnostic marker for chronic kidney disease.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Santhera Announces First Patient Dosing with Omigapil in CMD
Company announces full patient recruitment of CALLISTO study.
Study Shows Promise of Precision Medicine for Most Common Type of Lymphoma
The study appeared online July 20, 2015, in Nature Medicine.
HIV Control Through Treatment Durably Prevents Heterosexual Transmission of Virus
NIH-funded trial proves suppressive antiretroviral therapy for HIV-infected people effective in protecting uninfected partners.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!